Analysed BIOARCTIC AB (BRCTF:OTCMKTS) News Sources
Lilly and BioArctic sign deal to develop neurodegenerative therapy
23-06-2026
pharmaceutical-technology.com
The Bull Case For Eli Lilly (LLY) Could Change Following New Multi‑Target R&D Alliances With Biotechs
25-06-2026
yahoo.com
Eli Lilly (LLY) and BioArctic AB Enter into Research and Collaboration Agreement
27-06-2026
yahoo.com
New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
30-06-2026
yahoo.com
New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease
13-07-2026
yahoo.com
FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease
14-07-2026
yahoo.com
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
14-07-2026
yahoo.com
What is the current price of BIOARCTIC AB (BRCTF:OTCMKTS)?
The current price of BIOARCTIC AB (BRCTF:OTCMKTS) is $0.
BIOARCTIC AB (BRCTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BIOARCTIC AB (BRCTF:OTCMKTS) since the previous trading day is $None.
BIOARCTIC AB (BRCTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BIOARCTIC AB (BRCTF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for BIOARCTIC AB (BRCTF:OTCMKTS)?
The most recent average sentiment score for BIOARCTIC AB (BRCTF:OTCMKTS) is 84 out of 100.
What is the most recent average sentiment for BIOARCTIC AB (BRCTF:OTCMKTS)?
The most recent sentiment for BIOARCTIC AB (BRCTF:OTCMKTS) is .
SEC-8K** Filing Available For BIOARCTIC AB (BRCTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.